ArticleJournal of the American Medical Directors Association2026
State POLST Program Maturity Status and Dying in the Nursing Home or Hospice in the United States: An Event Time Study.
Article in Journal of the American Medical Directors Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectivesState Physician Orders for Life-Sustaining Treatment (POLST) programs ensure orders for treatment are documented for the provision of goal-concordant care at the end of life. The national POLST organization tracks the maturity stages of state programs and categorizes them as developed (beginning of use) and endorsed (benchmarks and standardized use). Examining the association between POLST program maturation and the likelihood of dying in place can help clarify how implementation stage may affect end-of-life care and place of death. This study examined the association between the state POLST program maturity stage with place of death of nursing home (NH) residents (eg, nursing home or hospice).
designAn event time study. SETTING AND
participantsThis study included a 10% random sample of NH residents aged 65 and older who died between 2012 and 2018 in the United States.
methodsData for NH residents were merged with data on each state's POLST development and endorsement year. Place and date of death were identified using the Minimum Data Set 3.0 and National Vital Statistics. A linear probability model assessed the likelihood of dying in a NH or hospice vs elsewhere before and after POLST implementation.
resultsAmong 225,149 NH residents, 74.3% had Alzheimer's disease or dementia, 67% were women, and 82.2% were White. Following POLST program development, the probability of dying in a NH or hospice increased by 1.6 percentage points (pp) in the first year (95% CI, 0.006-0.027; P = .003) and by 5.6 pp after 5 years (95% CI, 0.041-0.070). A sustained increase in likelihood of dying in place was also observed after POLST endorsement. CONCLUSIONS AND IMPLICATIONS: POLST program maturity is associated with a higher likelihood of NH residents dying in place or in hospice, potentially supporting goal-concordant care and reducing burdensome hospital transfers near the end of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.